A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma. uri icon

authors

  • Sborov, Douglas W
  • Grever, Michael R
  • Hofmeister, Craig C
  • Nuovo, Gerard J
  • Stiff, Andrew
  • Mace, Thomas
  • Lesinski, Gregory B
  • Benson, Don M
  • Efebera, Yvonne A
  • Ashley E. Rosko, MD
  • Pichiorri, Flavia

publication date

  • January 1, 2014